Applied Biosytems will transfer its Voyager MALDI-TOF and 4700 MALDI-TOF/TOF instruments to its joint venture with MDS, the company said last week. This joint venture already produces a number of mass spectrometers sold by ABI, which will continue to market, sell, and service the systems.

R&D and manufacturing of the Voyager and 4700 mass spectrometers, the only ones currently produced by ABI in-house, as well as related intellectual property, will be moved to the Applied Biosystems/MDS Sciex Instruments joint venture in Toronto.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.